Tempus AI

Tempus AI Goodwill/Assets

The Goodwill to Total Assets Ratio of Tempus AI (TEM) as of Oct 16, 2026 is 20.67 %. In the previous year, Goodwill to Total Assets Ratio was 7.92 % — a change of 161.01% (higher).

Goodwill/Assets

20.67 %

YoY

161.01%

Last updated:

Goodwill to Total Assets Ratio of Tempus AI is 2025 20.67 % . Goodwill to Total Assets Ratio of Tempus AI was 2024 7.92 % . It decreases by 161.01% higher compared to the previous year.

The Tempus AI Goodwill/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill/Assets
Date
Goodwill/Assets
Jan 1, 2019
4.32 USD
Jan 1, 2020
2.13 USD
Jan 1, 2021
3.01 USD
Jan 1, 2022
8.41 USD
Jan 1, 2023
13.00 USD
Jan 1, 2024
7.92 USD
Jan 1, 2025
20.67 USD
The Tempus AI Goodwill/Assets history
YEARGoodwill/AssetsYoY
20.67 %+161.01%
7.92 %-39.10%
13.00 %+54.63%
8.41 %+179.57%
3.01 %+41.45%
2.13 %-50.75%
4.32 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc, listed on the stock market with ticker TEM and ISIN US88023B1035, is a U.S.-based company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Chicago, the company employs approximately 3,800 people. Tempus AI Inc completed its initial public offering (IPO) on June 14, 2024. The company's website is www.tempus.com. Tempus AI Inc provides next-generation diagnostics across multiple disease areas, utilizing data and analytics to support personalized medicine. Its product offerings include genomics, data analytics, and artificial intelligence applications. The genomics division operates laboratories that deliver next-generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and various anatomic and molecular pathology testing services. The AI applications division focuses on developing algorithmic diagnostics, software as a medical device, and clinical decision support tools. The company's primary AI platform, Next, uses machine learning to analyze routinely generated data, aiming to proactively identify and address care gaps for patients in oncology and cardiology. Tempus AI Inc is positioned as a technology company within the life sciences sector, leveraging advanced data capabilities to enhance medical care and treatment personalization. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

Goodwill to Total Assets Ratio of Tempus AI is 20.67 % in 2025.

Goodwill to Total Assets Ratio of Tempus AI changed from 7.92 % to 20.67 %, representing a 161.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Tempus AI since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Tempus AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Tempus AI

All Key Metrics — Tempus AI